What amount sold does ANALYTICAL BIO CHEMISTRY LABORATORIES INC report in Form D filings?

The latest linked filings report $575K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was ANALYTICAL BIO CHEMISTRY LABORATORIES INC's most recent SEC filing?

ANALYTICAL BIO CHEMISTRY LABORATORIES INC's most recent Form D filing was on 2009-05-08.

How many investors does ANALYTICAL BIO CHEMISTRY LABORATORIES INC have?

The most recent Form D filing lists 13 investor(s).

What type of securities does ANALYTICAL BIO CHEMISTRY LABORATORIES INC offer?

ANALYTICAL BIO CHEMISTRY LABORATORIES INC's SEC Form D filings indicate equity offerings.

ANALYTICAL BIO CHEMISTRY LABORATORIES INC

CIK: 0000932570·Biotechnology·COLUMBIA, MO·Corporation

Reported Sold

$574,984

Total Filings

Identified Offerings

Last Filed

May 8, 2009

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

May 8, 2009Form D — New notice

Reported sold: $574,984 · Target: $574,984

Rule 506·13 investors

Fundraising Profile

Exemptions

Rule 506

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$574,984

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
May 8, 2009	New	$574,984	$574,984	13

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Opus KSD, Inc.

Biotechnology

Offering target: $680,801

Filed Oct 1, 2026